JC Tardiff - Circulation research, 2011 - Am Heart Assoc
Sixteen years ago, mutations in cardiac troponin (Tn) T and α-tropomyosin were linked to familial hypertrophic cardiomyopathy, thus transforming the disorder from a disease of the β …
Background: Whole genome sequencing (WGS) is a comprehensive genetic testing approach that reports most types of nucleotide variants. Objectives: This study sought to …
Cardiac muscle relaxation is an essential step in the cardiac cycle. Even when the contraction of the heart is normal and forceful, a relaxation phase that is too slow will limit …
C Ferrantini, R Coppini, JM Pioner… - Journal of the …, 2017 - Am Heart Assoc
Background In cardiomyocytes from patients with hypertrophic cardiomyopathy, mechanical dysfunction and arrhythmogenicity are caused by mutation‐driven changes in myofilament …
PE Cryer - The Journal of clinical investigation, 2006 - Am Soc Clin Investig
A reduced sympathoadrenal response, induced by recent antecedent hypoglycemia, is the key feature of hypoglycemia-associated autonomic failure (HAAF) and, thus, the …
Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity. We investigated the molecular basis of the cardiac phenotype in two mouse models at …
The cardiac thin filament regulates actomyosin interactions through calcium-dependent alterations in the dynamics of cardiac troponin and tropomyosin. Over the past several …
MR Williams, SJ Lehman, JC Tardiff… - Proceedings of the …, 2016 - National Acad Sciences
Calcium binding and dissociation within the cardiac thin filament (CTF) is a fundamental regulator of normal contraction and relaxation. Although the disruption of this complex …
Y Cheng, M Regnier - Archives of biochemistry and biophysics, 2016 - Elsevier
Cardiac troponin (cTn) acts as a pivotal regulator of muscle contraction and relaxation and is composed of three distinct subunits (cTnC: a highly conserved Ca 2+ binding subunit, cTnI …